Citation: | YANG Yang, RUAN Su, LIANG Hui, CHEN Qiaolan, YAN Nianwen, HUANG Yanping. Clinical Study of Huatan Tongluo Decoction in the Treatment of Post-Stroke Cognitive Impairment Based on BDNF Pathway[J]. Journal of Nanjing University of traditional Chinese Medicine, 2024, 40(9): 979-984. DOI: 10.14148/j.issn.1672-0482.2024.0979 |
To observe the clinical efficacy of Huatan Tongluo Decoction in the treatment of post-stroke cognitive impairment (PSCI) with phlegm stasis obstructing collaterals syndrome, and its influence on the serum brain-derived neurotrophic factor (BDNF) pathway-related factors.
Sixty patients who met the inclusion criteria were collected and randomly divided into a control group and a treatment group with 30 patients each. The control group was given basic treatment and nimodipine, while the treatment group was given Huatan Tongluo Decoction on the basis of the treatment in the control group. The treatment course for both groups was 4 weeks. Changes in Mini-Mental State Examination (MMSE), TCM syndrome scores and serum levels of BDNF, nuclear transcription factor κB(NF-κB), B lymphocyte tumor-2 (Bcl-2) and Bcl-2-associated X protein (Bax) were compared between the two groups before and after treatment. The TCM clinical efficacy in the two groups of patients was evaluated after treatment, and the occurrence of adverse reactions was observed during treatment.
After treatment, the MMSE scores of the patients in the two groups increased significantly, the total TCM syndrome scores decreased significantly (P < 0.01), and the treatment group was better than the control group (P < 0.01); the serum BDNF, NF-κB, and Bcl-2 levels of the two groups of patients were significantly increased (P < 0.05, P < 0.01), and the Bax level was significantly decreased (P < 0.01). The treatment group was better than the control group (P < 0.01).
Huatan Tongluo Decoction can improve the clinical symptoms of PSCI patients with phlegm stasis obstructing collaterals, and is safe and effective. Its therapeutic mechanism may be related to regulating the BDNF pathway to protect nerve cells and inhibit nerve cell apoptosis.
[1] |
中国卒中学会血管性认知障碍分会. 卒中后认知障碍管理专家共识2021[J]. 中国卒中杂志, 2021, 16(4): 376-389.
Chinese Stroke Society Vascular Cognitive Impairment Branch. Experts consensus on post-stroke cognitive impairment management 2021 Chinese society of vascular cognitive impairment[J]. Chin J Stroke, 2021, 16(4): 376-389.
|
[2] |
王楠, 薛安宁, 高利娜, 等. 中药治疗卒中后认知障碍作用机制的研究进展[J]. 中西医结合心脑血管病杂志, 2024, 22(8): 1452-1456.
WANG N, XUE A N, GAO L N, et al. Research progress on the mechanism of traditional Chinese medicine in treating cognitive impairment after stroke[J]. Chin J Integr Med Cardio Cerebrovasc Dis, 2024, 22(8): 1452-1456.
|
[3] |
朱方丽, 焦富英. 痴呆的病因病机[J]. 实用中医内科杂志, 2022, 36(4): 38-40.
ZHU F L, JIAO F Y. Analysis of etiology and pathogenesis of dementia[J]. J Pract Tradit Chin Intern Med, 2022, 36(4): 38-40.
|
[4] |
靳洁, 黄世敬. 中药复方治疗脑卒中后认知障碍的研究进展[J]. 中西医结合心脑血管病杂志, 2023, 21(19): 3558-3562.
JIN J, HUANG S J. Research progress of traditional Chinese medicine compound in treating cognitive impairment after stroke[J]. Chin J Integr Med Cardio Cerebrovasc Dis, 2023, 21(19): 3558-3562.
|
[5] |
杨洋, 梁晖, 陈甦, 等. 化痰通络汤治疗风痰阻络型急性脑梗死临床观察[J]. 福建中医药, 2021, 52(1): 52-53.
YANG Y, LIANG H, CHEN S, et al. Clinical observation on Huatan Tongluo Decoction in the treatment of acute cerebral infarction with wind-phlegm blocking collaterals[J]. Fujian J Tradit Chin Med, 2021, 52(1): 52-53.
|
[6] |
杨洋, 梁晖, 陈甦, 等. 化痰通络汤对急性脑梗死患者血清SOD及MDA水平的影响[J]. 福建中医药, 2020, 51(5): 66-67.
YANG Y, LIANG H, CHEN S, et al. Effect of Huatan Tongluo Decoction on serum SOD and MDA levels in patients with acute cerebral infarction[J]. Fujian J Tradit Chin Med, 2020, 51(5): 66-67.
|
[7] |
杨洋, 陈甦, 许成, 等. 化痰通络汤治疗痰瘀阻络型卒中后认知功能障碍的临床效果[J]. 中外医学研究, 2023, 21(34): 5-10.
YANG Y, CHEN S, XU C, et al. Clinical effect of Huatan Tongluo Decoction in the treatment of patients with post-stroke cognitive impairment of phlegm stasis obstructs collaterals[J]. Chin Foreign Med Res, 2023, 21(34): 5-10.
|
[8] |
中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等. 缺血性卒中基层诊疗指南(2021年)[J]. 中华全科医师杂志, 2021, 20(9): 927-946.
Chinese Medical Association, Chinese Medical Journals Publishing House, Chinese Society of General Practice, et al. Guideline for primary care of ischemic stroke (2021)[J]. Chin J Gen Prac, 2021, 20(9): 927-946.
|
[9] |
中药新药临床研究指导原则: 试行[M]. 北京: 中国医药科技出版社, 2002: 91-97.
Guiding principles for clinical research of new Chinese medicine: Trial implementation[M]. Beijing: China Medical Science Press, 2002: 91-97.
|
[10] |
崔一之, 赵佳琪, 董旭, 等. 中医药治疗脑卒中后认知功能障碍的研究进展[J]. 中医药信息, 2022, 39(11): 75-79.
CUI Y Z, ZHAO J Q, DONG X, et al. Research progress of TCM in treating Post-Stroke cognitive dysfunction[J]. Inf Tradit Chin Med, 2022, 39(11): 75-79.
|
[11] |
赵玉杰, 路保全, 原娟. 温胆汤合瓜蒌薤白桂枝汤治疗脑卒中后认知障碍疗效观察[J]. 实用中医药杂志, 2024, 40(4): 621-623.
ZHAO Y J, LU B Q, YUAN J. Observation on the therapeutic effect of Wendan Decoction combined with Gualou Xiebai Guizhi Decoction on cognitive impairment after stroke[J]. J Pract Tradit Chin Med, 2024, 40(4): 621-623.
|
[12] |
高利娜, 巩婷, 胡亮亮, 等. 基于"瘀血"探讨铁代谢失衡与卒中后认知障碍的相关性[J]. 现代中西医结合杂志, 2024, 33(8): 1091-1095.
GAO L N, GONG T, HU L L, et al. Discussion on the correlation between iron metabolism imbalance and cognitive impairment after stroke based on "blood stasis"[J]. Mod J Integr Tradit Chin West Med, 2024, 33(8): 1091-1095.
|
[13] |
方嵘, 陈生弟. 神经可塑性机制在卒中后认知功能恢复中的作用[J]. 中风与神经疾病杂志, 2024, 41(5): 387-394.
FANG R, CHEN S D. Role of neuroplasticity in the recovery of cognitive function after stroke[J]. J Apoplexy Nerv Dis, 2024, 41(5): 387-394.
|
[14] |
周小燕, 杨丹, 张敏, 等. 老年帕金森病患者血清PARK2、GFAP和BDNF表达对疾病分期和认知功能的评估[J]. 中国老年学杂志, 2023, 43(9): 2142-2145.
ZHOU X Y, YANG D, ZHANG M, et al. The expression of PARK2, GFAP, and BDNF in serum of elderly Parkinson's disease patients for assessment of disease staging and cognitive function[J]. Chin J Gerontol, 2023, 43(9): 2142-2145.
|
[15] |
SUN Y, ZHANG H L, WU Z J, et al. Quercitrin rapidly alleviated depression-like behaviors in lipopolysaccharide-treated mice: The involvement of PI3K/AKT/NF-κB signaling suppression and CREB/BDNF signaling restoration in the hippocampus[J]. ACS Chem Neurosci, 2021, 12(18): 3387-3396.
|
[16] |
HASHEM K S, ELKELAWY A M M H, ABD-ALLAH S, et al. Involvement of Mfn2, Bcl2/Bax signaling and mitochondrial viability in the potential protective effect of Royal jelly against mitochondria-mediated ovarian apoptosis by cisplatin in rats[J]. Iran J Basic Med Sci, 2020, 23(4): 515-526.
|
[17] |
SPITZ A Z, GAVATHIOTIS E. Physiological and pharmacological modulation of BAX[J]. Trends Pharmacol Sci, 2022, 43(3): 206-220.
|
[18] |
冯韬, 吕烨华, 王盛, 等. 黄芪注射液对大鼠急性脊髓损伤的神经保护作用及机制研究[J]. 南京中医药大学学报, 2022, 38(12): 1128-1135.
FENG T, LV YH, WANG S, et al. Neuroprotective effect and mechanism of astragalus injection on acute spinal cord injury in rats[J]. J Nanjing Univ Tradit Chin Med, 2022, 38(12): 1128-1135
|
[19] |
ZHANG J Y, XIE Y D, FAN Q L, et al. Effects of karanjin on dimethylhydrazine induced colon carcinoma and aberrant crypt foci are facilitated by alteration of the p53/Bcl2/BAX pathway for apoptosis[J]. Biotech Histochem, 2021, 96(3): 202-212.
|
[20] |
朱晓春, 夏振江, 沈庆红, 等. 半夏炮制方法及其现代研究进展[J]. 上海中医药杂志, 2023, 57(7): 81-87.
ZHU X C, XIA Z J, SHEN Q H, et al. Processing methods and modern research progress of Pinelliae Rhizoma[J]. Shanghai J Tradit Chin Med, 2023, 57(7): 81-87.
|
[21] |
邓楚欣, 于征淼, 林培政, 等. 半夏生物总碱对癫痫大鼠行为学、脑组织病理学及BDNF/Trk-B表达的影响[J]. 吉林中医药, 2021, 41(12): 1652-1656.
DENG C X, YU Z M, LIN P Z, et al. Effects of pinellia total alkaloids on neuroethology, brain histopathology and BDNF/Trk-B expression in epileptic rats[J]. Jilin J Chin Med, 2021, 41(12): 1652-1656.
|
[22] |
赵广平, 史炯, 程晶晶, 等. 川陈皮素对麻醉后老龄认知功能障碍大鼠学习记忆功能损伤的改善作用[J]. 川北医学院学报, 2021, 36(6): 689-695.
ZHAO G P, SHI J, CHENG J J, et al. Mechanism of nobiletinon improving learning and memory function of eld-erly rats with cognitive disorder after anesthesia[J]. J N Sichuan Med Coll, 2021, 36(6): 689-695.
|
[23] |
牛芬溪, 桑旭星, 杨依, 等. 远志寡糖酯对β淀粉样蛋白25~35诱导的SH-SY5Y神经细胞损伤及AKT/CREB/BDNF信号通路的影响[J]. 北京中医药大学学报, 2022, 45(4): 414-420.
NIU F X, SANG X X, YANG Y, et al. Effects of oligosaccharide esters of polygala tenuifolion on β-Amyloid protein 25-35 induced SH-SY5Y cell injury and AKT/CREB/BDNF signal pathway[J]. J Beijing Univ Tradit Chin Med, 2022, 45(4): 414-420.
|
[24] |
马竞, 何文龙, 高重阳, 等. 党参多糖介导Nrf2通路对缺氧缺血性脑损伤的抗氧化和神经保护作用[J]. 中国临床解剖学杂志, 2019, 37(4): 403-408.
MA J, HE W L, GAO C Y, et al. Antioxidant and neuroprotective effects of Codonopsis pilosula polysaccharides on hypoxic-ischemic brain injury induced by Nrf2 pathway[J]. Chin J Clin Anat, 2019, 37(4): 403-408.
|
[25] |
ZHAO T F, FU Y X, SUN H, et al. Ligustrazine suppresses neuron apoptosis via the Bax/Bcl-2 and caspase-3 pathway in PC12 cells and in rats with vascular dementia[J]. IUBMB Life, 2018, 70(1): 60-70.
|
[26] |
陈路, 李玮玮, 刘春慧. 药对丹参-红花对脑缺血再灌注损伤大鼠脑保护作用的研究[J]. 中药药理与临床, 2017, 33(1): 161-166.
CHEN L, LI W W, LIU C H. Neruroprotective effect of Salviamiltiorrhiza-Safflower on cerebral ischemia reperfusion injury in rats[J]. Pharmacol Clin Chin Mater Med, 2017, 33(1): 161-166.
|